Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 20
2003 22
2004 34
2005 50
2006 79
2007 69
2008 89
2009 148
2010 161
2011 208
2012 230
2013 287
2014 351
2015 363
2016 433
2017 477
2018 516
2019 631
2020 684
2021 828
2022 1036
2023 1036
2024 1195
2025 1435
2026 290

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,506 results

Results by year

Filters applied: . Clear all
Page 1
Chinese Immune Multi-Omics Atlas.
Yin J, Zheng Y, Huang Z, Zhou W, Yuan Y, Cai P, Bai Y, Yang S, Gao Y, Duan S, Wang Y, Xu Z, Zhang W, Zhang X, Wei Y, Huang Y, Liu Y, Wang W, Yang T, Zhang Z, Chen X, Zhang X, Lv J, Li F, Zhang Y, Zeng G, Wang X, Ma W, Hou G, Hao S, Liu C, Lai Y, Liu P, Wang B, Li Y, Zhang W, Gao P, Xie J, Esteban MA, Gu Y, Liu X, Ji J, Qi T, Liu B, Wang H, Zhao Y, Yang X, Wang X, Chen R, Yang J, Yin Y, Wang J, Cao Y, Xu X, Liu L, Jin X, Liu C. Yin J, et al. Among authors: liu x. Science. 2026 Jan 8;391(6781):eadt3130. doi: 10.1126/science.adt3130. Epub 2026 Jan 8. Science. 2026. PMID: 41505528
Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes.
Gao X, Zhao S, Du Y, Yang Z, Tian Y, Zhao J, Yuan X, Santos BR, Wei D, Cui L, Yan J, Qin Y, Shi Y, Tang R, Sun Y, Hu J, Ding L, Song X, Ha L, Li J; China Women’s Reproductive Metabolic Network; Zhang H, Spritzer PM, Yildiz BO, Stener-Victorin E, Yong EL, Ou XH, Legro RS, Zhao H, Chen ZJ. Gao X, et al. Nat Med. 2025 Dec;31(12):4214-4224. doi: 10.1038/s41591-025-03984-1. Epub 2025 Oct 29. Nat Med. 2025. PMID: 41162652 Free PMC article.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
NRF1-mediated innate immune response drives inflammaging.
Lei H, Zhao T, Zhang J, Long Y, Chen Y, Zhu Y, Meng Y, Tang Y, Liu X, Sun J, Li Z, Su J, Gong F, Chen G, Sun B, Chen Y, Chen Q, Li Y, Zhu Y. Lei H, et al. Among authors: liu x. Nat Commun. 2025 Dec 11;16(1):11367. doi: 10.1038/s41467-025-66368-6. Nat Commun. 2025. PMID: 41381492 Free PMC article.
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team. Dorman SE, et al. Among authors: liu x. Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Lancet Infect Dis. 2018. PMID: 29198911 Free PMC article.
Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial.
Hou Z, Dong B, Yao Q, Chen H, Shao Q, Li M, Wang J, Chen K, Zhu Z, Peng F, Wei S, Hu X, Li J, Liu M, Xu B, Zheng S, Bi N, Zheng S, Xu Q, Chen B, Wu C, Li R, Chen W, Liu X, Tian Y, Li X, Guo S, Zhao L, Zhu Y, Cai L, Li Q, Li L, Zhang H, Hu C, Wang L, Li Q, Chen B, Chen M. Hou Z, et al. Among authors: liu x. Lancet Oncol. 2025 Dec;26(12):1552-1562. doi: 10.1016/S1470-2045(25)00515-7. Epub 2025 Nov 6. Lancet Oncol. 2025. PMID: 41207313 Clinical Trial.
9,506 results